Home
Editorial
Services
Interview
Q&A
Chronicle Specials
Pharma Mart
ePharmail
Archives
Tenders & Project
Tenders & Enquiries
Pharma Projects
Corporate
Company Profiles
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
Rappta Therapeutics enters global license agreement with SpringWorks for a pre-clinical first-in-class molecular glue targeting PP2A
Join Pharma
|
Login
Editorial
MAKE HOSPITALS A SAFER PLACE
Wednesday, January 8, 2025
Delhi Chief Minister Atishi has triggered a debate over the need for framing laws for the protection of healthcare professionals, especially the doctors. Addressing the Annual Conference of the Delhi State Medical Association recently
Past Editorial...
TODAY'S NEWS
18:00 [IST]
Rappta Therapeutics enters global license agreement with SpringWorks for a pre-clinical first-in-class molecular glue targeting PP2A
17:00 [IST]
Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun
16:00 [IST]
Novartis Entresto US patent upheld by US Court of Appeals
15:00 [IST]
Telix to buy next-generation therapeutic assets and innovative biologics technology platform from ImaginAb
14:00 [IST]
US FDA accepts and grants priority review status to AstraZeneca & Daiichi Sankyo’s BLA for Dato-DXd for patients with previously treated advanced EGFR-mutated NSCLC
13:00 [IST]
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
more news >>
TOP NEWS
08:00 [IST]
PDMA asks govt to create separate category for units below Rs. 10 crore & allow 3 years to implement revised Schedule M
08:00 [IST]
FOPE urges govt to extend revised Schedule M implementation to December 31, 2026
08:00 [IST]
HPMA demands three years’ time for full compliance with revised Schedule M
08:00 [IST]
Pharmacy Council of India fixes staff to students ratio for B.Pharm as 1:20
08:00 [IST]
India initiates anti-dumping probe on Resorcinol imports from China and Japan
08:00 [IST]
Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing
more news >>
YESTERDAY'S NEWS
18:00 [IST]
Nektar Therapeutics completes target enrollment in REZOLVE-AD phase 2b trial of rezpegaldesleukin in patients with moderate-to-severe atopic dermatitis
17:00 [IST]
Qiagen increases QIAcuity Digital PCR High-Order Multiplexing capabilities to gain deeper insights from biological samples
16:40 [IST]
Lupin introduces Minzoya in US market
13:35 [IST]
GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion
12:45 [IST]
Aragen secures $100 million investment from Quadria Capital
12:15 [IST]
AIG Group of Hospitals in Hyderabad to invest Rs. 800 crore in Proton Beam Therapy to treat complex cancers
more news >>
INTERVIEW
Molbio Diagnostics redefines molecular diagnostics with Truenat
Shiva Sriram, President of Molbio Diagnostics
Past Interviews...
What's New?
Clopidogrel 75mg And Aspirin 75mg Tab
Atorvastatin 10 Mg +aspirin 75 Mg (plain/delayed Release).
Insulin Degludec And Aspart 100 Iu/ml-3 Ml (ryzodeg Flex Touch Pen)
Clindamycin 100 Mg + Clotrimazole 200 Mg + Tinidazole 100 Mg (vaginal)
Citicoline 500 Mg + Piracetam 400 Mg
Opinion Poll
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
Yes
No
Can't Say
View Past Poll
Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
Special Features
Features
Chronicle Pharmabiz Specials
Forthcoming
Past
Forthcoming Events
International
Domestic
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
Copyright © 2024 Saffron Media Pvt. Ltd |
About us
|
Contact us
|
Advertise
|
Feedback
|
Helpdesk
|
Disclaimer
|
Sitemap
|
Archives
|
Terms & Conditions